TechNavio's analysts forecast the Global Over-the-counter (OTC) Pharmaceutical market to grow at a CAGR of 1.9 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing switch from prescription to OTC drugs. The Global Over-the-counter Pharmaceutical market has also been witnessing the trend of an increasing number of mergers and acquisitions. However, the increasing risks of side-effects could pose a challenge to the growth of this market.
TechNavio's report, the Global Over-the-counter Pharmaceutical Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Over-the-counter Pharmaceutical market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this market space are Bayer Healthcare AG, Johnson & Johnson, GlaxoSmithKline plc, and Novartis International AG.
The other vendors mentioned in the report are Sanofi S.A., Reckitt Benckiser plc, Boehringer Ingelheim GmbH , Merck and Co. Inc., Pfizer Inc., Takeda Pharmaceutical Co. Ltd., Roche Holding Ltd., Procter and Gamble, Taisho Pharmaceutical, Bristol Myers Squibb Co., Schering-Plough Corp., Eisai Co. Ltd., Mitsubishi Tanabe Pharma Corp., Sigma Pharmaceuticals plc, Hubei Biocause Heilen Pharmaceutical Co. Ltd., United Laboratories Inc., Daewoong Pharmaceutical Co. Ltd., Bukwang Pharmaceutical Co. Ltd., Vida Laboratories Ltd., and Cipla Ltd.
Key questions answered in this report:
What will the market size be in 2016 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
01. Executive Summary
03. Market Coverage
04. Market Landscape
Market Size and Forecast
04.1 Five Forces Analysis
05. Geographical Segmentation
06. Key Leading Countries
07. Vendor Landscape
Product Portfolio Matrix
08. Buying Criteria
09. Market Growth Drivers
10. Drivers and their Impact
11. Market Challenges
12. Impact of Drivers and Challenges
13. Market Trends
14. Key Vendor Analysis
14.1 Bayer HealthCare AG
14.2 Johnson & Johnson
14.3 GlaxoSmithKline plc
14.4 Novartis International AG
15. Other Reports in this Series
List of Exhibits:
Exhibit 1: Global Over-the-counter Pharmaceuticals Market 2012â2016 (US$ billion)
Exhibit 2: Global Over-the-counter Pharmaceuticals Market by Product Segmentation
Exhibit 3: Global Over-the-counter Pharmaceuticals Market by Product Segmentation 2012
Exhibit 4: Global Over-the-counter Pharmaceuticals Market by Geographical Segmentation 2012
Exhibit 5: Global Over-the-counter Pharmaceuticals Market by Vendor Segmentation 2012
Exhibit 6: Business Segmentation of Bayer HealthCare AG
Exhibit 7: Business Segmentation of Johnson & Johnson
Exhibit 8: Business Segmentation of GlaxoSmithKline plc
Exhibit 9: Business Segmentation of Novartis International AG